Syngene International Q4 Results
- BSE: 539268
- NSE: SYNGENE
- ISIN: INE398R01022
- Sector: Biotechnology & Drugs
BSE
434.50
-1.00 (-0.23%)
-1.00 (-0.23%)Volume13.53 K
Updated: Fri 5 Jun, 2026 | 15:29:51
NSE
434-1.55 (-0.36%)
-1.55 (-0.36%)Volume2.89 L
Updated: Fri 5 Jun, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1,036.50 Cr.(1.82%)
- Operating Profit₹207.00 Cr.(-14.50%)
- Profit After Tax₹147.90 Cr.(-19.31%)
- Operating Margin19.97%(-16.02%)
Note: Comparison is on YoY basis
Quarterly - Syngene International Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 829.50 | 869.00 | -4.55% | 698.60 | 6.91% |
| Depreciation/ Amortization | 111.50 | 113.70 | -1.93% | 111.10 | 5.09% |
| Operating Income | 207.00 | 48.10 | 330.35% | 218.30 | -14.50% |
| Net Income | 147.90 | 15.00 | 886.00% | 188.60 | -19.31% |
| Other Operating Expenses Total | 178.10 | 187.90 | -5.22% | 152.30 | -2.04% |
| Net Income Before Taxes | 196.00 | 28.40 | 590.14% | 209.00 | -18.50% |
| Total Revenue | 1,036.50 | 917.10 | 13.02% | 916.90 | 1.82% |
| Selling/ General/ Admin Expenses Total | 300.80 | 267.40 | 12.49% | 232.40 | 18.89% |
| Diluted Normalized EPS | 3.78 | 1.29 | 193.25% | 4.75 | -16.58% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.